PREDICT STUDY FINAL RESULTS: EFFICACY AND SAFETY OF 24-WK REGIMEN OF PEGINTERFERON ALFA-2B PLUS WEIGHT-BASED RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) GENOTYPE 1 (G1) WITH LOW VIRAL LOAD WHO ACHIEVE RAPID VIRAL RESPONSE

Craxi A.¹ , Zuckerman E.² , Koutsounas S.³ , Ogurtsov P.P. ⁴ , Chemello L.⁵ , Maticic M.B.⁶ , Torras X.⁷ , Diago M.⁸ , Tartaglione M.⁹ , Witthoeft T.¹⁰ , Yu X.¹¹ , Chaudhri E.I.¹¹ , Pedicone L.¹¹ , Faruqi R.¹¹

HEPATOLOGY

WILEY-BLACKWELL

4

Английский

Опубликовано

50

2009

• ¹ Univ Palermo, Palermo, Italy
• ² Carmel Hosp, Liver Unit, Haifa, Israel
• ³ 1st Hosp IKA PENTELI, Mellisia, Greece
• ⁴ Russian Univ People Friendship, Moscow, Russia
• ⁵ Univ Padua, Padua, Italy
• ⁶ Univ Med Ctr Ljubljana, Dept Infect Dis & Febrile Illnesses, Ljubljana, Slovenia
• ⁷ Hosp Santa Creu & Sant Pau, Barcelona, Spain
• ⁸ Hosp Gen Valencia, Valencia, Spain
• ⁹ Cardarelli Hosp, Naples, Italy
• ¹⁰ Univ Hosp Schleswig Holstein, Lubeck, Germany
• ¹¹ Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA

19.10.2018

19.10.2018

https://repository.rudn.ru/ru/records/article/record/8646/